MX366595B - Forma de dosificacion de pelicula oral humectable al instante sin surfactante o polialcohol. - Google Patents

Forma de dosificacion de pelicula oral humectable al instante sin surfactante o polialcohol.

Info

Publication number
MX366595B
MX366595B MX2016001399A MX2016001399A MX366595B MX 366595 B MX366595 B MX 366595B MX 2016001399 A MX2016001399 A MX 2016001399A MX 2016001399 A MX2016001399 A MX 2016001399A MX 366595 B MX366595 B MX 366595B
Authority
MX
Mexico
Prior art keywords
vinylpyrrolidone
polyalcohol
surfactant
dosage form
copolymer
Prior art date
Application number
MX2016001399A
Other languages
English (en)
Other versions
MX2016001399A (es
Inventor
G Zerbe Horst
Angusti Angela
Paiement Nadine
Original Assignee
Intelgenx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52428223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX366595(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intelgenx Corp filed Critical Intelgenx Corp
Publication of MX2016001399A publication Critical patent/MX2016001399A/es
Publication of MX366595B publication Critical patent/MX366595B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma de dosificación de película oral rápidamente desintegrante y humectable al instante sin un surfactante y sin un polialcohol fue conseguida al combinar al menos un polímero soluble en agua que no es un copolímero de vinilpirrolidona, al menos un agente activo, un copolímero de vinilpirrolidona y un dióxido de titanio. En ciertas modalidades, la película comprende hidroxipropilcelulosa o una combinación de hidroxipropilcelulosa y un polímero o un copolímero de vinilpirrolidona o una vinilpirrolidona sustituida como el polímero(s) soluble en agua. Un plastificante y aditivos opcionales seleccionados a partir de edulcorantes sintéticos, edulcorantes naturales, saborizantes, antioxidantes, colorantes y opacificantes, pueden ser agregados a las formas descritas de dosificación oral de película.
MX2016001399A 2013-07-31 2014-07-30 Forma de dosificacion de pelicula oral humectable al instante sin surfactante o polialcohol. MX366595B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361860345P 2013-07-31 2013-07-31
PCT/IB2014/002047 WO2015015303A2 (en) 2013-07-31 2014-07-30 Instantly wettable oral film dosage form without surfactant or polyalcohol

Publications (2)

Publication Number Publication Date
MX2016001399A MX2016001399A (es) 2016-10-28
MX366595B true MX366595B (es) 2019-07-15

Family

ID=52428223

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016001399A MX366595B (es) 2013-07-31 2014-07-30 Forma de dosificacion de pelicula oral humectable al instante sin surfactante o polialcohol.

Country Status (18)

Country Link
US (1) US9301948B2 (es)
EP (2) EP3427732A1 (es)
JP (1) JP6482552B2 (es)
KR (1) KR102272442B1 (es)
CN (1) CN105530921B (es)
AU (1) AU2014298130A1 (es)
BR (1) BR112016002074B1 (es)
CA (1) CA2919442A1 (es)
CL (1) CL2016000160A1 (es)
DK (1) DK3027179T3 (es)
ES (1) ES2706481T3 (es)
HK (1) HK1222796A1 (es)
IL (1) IL243651A0 (es)
MX (1) MX366595B (es)
RU (1) RU2016106907A (es)
SG (1) SG11201600455XA (es)
WO (1) WO2015015303A2 (es)
ZA (1) ZA201600785B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160220480A1 (en) * 2015-02-03 2016-08-04 Intelgenx Corp. Oral dosage film exhibiting enhanced mucosal penetration
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
CN105997955B (zh) 2016-06-28 2017-09-12 力品药业（厦门）有限公司 一种帕洛诺司琼口腔膜剂及其制备方法
KR101802183B1 (ko) * 2016-11-16 2017-11-28 주식회사 유영제약 팔로노세트론을 활성성분으로 함유하는 약제학적 조성물
WO2019067667A1 (en) * 2017-09-27 2019-04-04 Aquestive Therapeutics, Inc. PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERMEATION
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
JP3460538B2 (ja) * 1997-10-08 2003-10-27 救急薬品工業株式会社 速溶性フィルム製剤
US7027414B2 (en) * 2001-08-09 2006-04-11 Hughes Network Systems, Llc Method, apparatus, and system for identifying and efficiently treating classes of traffic
EP1680079A4 (en) * 2003-10-24 2008-01-02 Adhesives Res Inc QUICKLY FILING FILMS FOR THE DISTRIBUTION OF PHARMACEUTICAL OR COSMETIC AGENTS
WO2005074894A1 (en) * 2004-01-30 2005-08-18 Corium International Rapidly dissolving film for delivery of an active agent
US20050281757A1 (en) * 2004-06-17 2005-12-22 Sayed Ibrahim Oral care film
WO2009074552A2 (en) 2007-12-11 2009-06-18 Novartis Ag Multi-zone films
CA2737307A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
US20100285130A1 (en) * 2009-05-06 2010-11-11 Monosol Rx, Llc Coating of complexed actives in film formulations
CN102665762A (zh) * 2009-11-24 2012-09-12 巴斯夫欧洲公司 膜状药物剂型
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
JP2012031164A (ja) * 2010-07-06 2012-02-16 Teika Seiyaku Kk フィルム状製剤
JP5587168B2 (ja) * 2010-12-28 2014-09-10 花王株式会社 医療器具用洗浄剤組成物
AR084865A1 (es) * 2011-01-17 2013-07-10 Takeda Pharmaceutical Preparacion de desintegracion rapida, comprimido dispersable por via oral
KR101303479B1 (ko) * 2011-07-28 2013-09-06 (주)씨엘팜 가식성 필름형성 조성물 및 약물이 함유된 가식성 필름형 제제
EP2995301B1 (en) * 2013-05-10 2019-08-07 CTC Bio, Inc. Film preparation containing donepezil-free base and method for producing same

Also Published As

Publication number Publication date
CN105530921B (zh) 2021-02-26
BR112016002074B1 (pt) 2023-01-24
CL2016000160A1 (es) 2016-11-18
WO2015015303A3 (en) 2015-05-21
US9301948B2 (en) 2016-04-05
SG11201600455XA (en) 2016-02-26
KR20160089335A (ko) 2016-07-27
JP2016527262A (ja) 2016-09-08
JP6482552B2 (ja) 2019-03-13
ES2706481T3 (es) 2019-03-29
KR102272442B1 (ko) 2021-07-02
MX2016001399A (es) 2016-10-28
IL243651A0 (en) 2016-02-29
CN105530921A (zh) 2016-04-27
EP3027179A4 (en) 2017-02-22
BR112016002074A2 (pt) 2017-08-01
WO2015015303A2 (en) 2015-02-05
EP3027179A2 (en) 2016-06-08
CA2919442A1 (en) 2015-02-05
DK3027179T3 (en) 2019-02-11
US20150038540A1 (en) 2015-02-05
AU2014298130A1 (en) 2016-02-11
EP3027179B1 (en) 2018-10-17
ZA201600785B (en) 2017-04-26
EP3427732A1 (en) 2019-01-16
HK1222796A1 (zh) 2017-07-14
RU2016106907A (ru) 2017-09-01

Similar Documents

Publication Publication Date Title
MX366595B (es) Forma de dosificacion de pelicula oral humectable al instante sin surfactante o polialcohol.
PH12017501321A1 (en) Oral care compositions and methods of use
MX355284B (es) Composiciones para cuidado oral que comprenden carbonato de calcio y arcilla.
PH12014501213A1 (en) Aqueous oral care compositions
MX352563B (es) Composiciones para el cuidado oral que contienen carbonato de calcio y silice.
WO2013142471A3 (en) Cross linked silicone copolmyer networks in a thickened aqueous phase
PH12016501034A1 (en) Oral care compositions and methods
PH12016500793A1 (en) Turmeric extract containing soft pastilles
MX2016004588A (es) Composiciones y metodos para la limpieza personal.
GEP20196984B (en) Pyridazine derivatives for use in the prevention or treatment of an ataxic disorder
MX361642B (es) Composiciones antisépticas catiónicas.
AR100456A1 (es) Composiciones dentífricas que tienen estabilidad de ión fluoruro y captación de fluoruro mejoradas
CA2969318C (en) Oral care compositions having high water content and micro robustness
PH12015502115A1 (en) Compositions and methods for live, attenuated alphavirus formulations
WO2013160349A3 (en) Cosmetic composition comprising a phosphorylated oligosaccharide and a polysaccharide
MX2016008211A (es) Composiciones para cuidado oral y metodos.
MX2016015017A (es) Composiciones dentifricas con estabilidad mejorada del fluoruro.
CA3056612A1 (en) Analogs of deutetrabenazine, their preparation and use
MX2015015537A (es) Formulacion de pastillas de nicotina.
MX2016002638A (es) Formulas de rehidratacion oral con prebioticos galactooligosacaridos.
MX2008009818A (es) Combinacion coccidicida para uso veterinario.
NZ736342A (en) Use of potassium hydroxide in the treatment of actinic keratosis
PL414541A1 (pl) Podchloryn sodu w żelu do zastosowania w stomatologii
MX2018005917A (es) Composiciones dentifricas con estabilidad mejorada del fluoruro.
MX2019000659A (es) Proceso para preparar composiciones para el cuidado bucal.

Legal Events

Date Code Title Description
FG Grant or registration